Last reviewed · How we verify

perineural dexmedetomidine

Guangzhou Women and Children's Medical Center · FDA-approved active Small molecule

perineural dexmedetomidine is a Alpha-2 adrenergic agonist Small molecule drug developed by Guangzhou Women and Children's Medical Center. It is currently FDA-approved for Perineural nerve block adjunct for postoperative analgesia, Regional anesthesia enhancement in pediatric and adult surgical procedures.

Perineural dexmedetomidine is an alpha-2 adrenergic agonist administered around nerves to provide prolonged local anesthesia and analgesia.

Perineural dexmedetomidine is an alpha-2 adrenergic agonist administered around nerves to provide prolonged local anesthesia and analgesia. Used for Perineural nerve block adjunct for postoperative analgesia, Regional anesthesia enhancement in pediatric and adult surgical procedures.

At a glance

Generic nameperineural dexmedetomidine
SponsorGuangzhou Women and Children's Medical Center
Drug classAlpha-2 adrenergic agonist
TargetAlpha-2 adrenergic receptor
ModalitySmall molecule
Therapeutic areaAnesthesia/Pain Management
PhaseFDA-approved

Mechanism of action

Dexmedetomidine binds to alpha-2 adrenergic receptors on nerve fibers, blocking pain signal transmission when delivered in the perineural space adjacent to target nerves. This produces extended sensory and motor blockade lasting several hours beyond the duration of conventional local anesthetics, reducing postoperative pain and opioid requirements.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about perineural dexmedetomidine

What is perineural dexmedetomidine?

perineural dexmedetomidine is a Alpha-2 adrenergic agonist drug developed by Guangzhou Women and Children's Medical Center, indicated for Perineural nerve block adjunct for postoperative analgesia, Regional anesthesia enhancement in pediatric and adult surgical procedures.

How does perineural dexmedetomidine work?

Perineural dexmedetomidine is an alpha-2 adrenergic agonist administered around nerves to provide prolonged local anesthesia and analgesia.

What is perineural dexmedetomidine used for?

perineural dexmedetomidine is indicated for Perineural nerve block adjunct for postoperative analgesia, Regional anesthesia enhancement in pediatric and adult surgical procedures.

Who makes perineural dexmedetomidine?

perineural dexmedetomidine is developed and marketed by Guangzhou Women and Children's Medical Center (see full Guangzhou Women and Children's Medical Center pipeline at /company/guangzhou-women-and-children-s-medical-center).

What drug class is perineural dexmedetomidine in?

perineural dexmedetomidine belongs to the Alpha-2 adrenergic agonist class. See all Alpha-2 adrenergic agonist drugs at /class/alpha-2-adrenergic-agonist.

What development phase is perineural dexmedetomidine in?

perineural dexmedetomidine is FDA-approved (marketed).

What are the side effects of perineural dexmedetomidine?

Common side effects of perineural dexmedetomidine include Hypotension, Bradycardia, Sedation, Dry mouth.

What does perineural dexmedetomidine target?

perineural dexmedetomidine targets Alpha-2 adrenergic receptor and is a Alpha-2 adrenergic agonist.

Related